CA2288439C - Biphenyl sulfonamides et leurs derives modulant l'activite de l'endotheline - Google Patents

Biphenyl sulfonamides et leurs derives modulant l'activite de l'endotheline Download PDF

Info

Publication number
CA2288439C
CA2288439C CA002288439A CA2288439A CA2288439C CA 2288439 C CA2288439 C CA 2288439C CA 002288439 A CA002288439 A CA 002288439A CA 2288439 A CA2288439 A CA 2288439A CA 2288439 C CA2288439 C CA 2288439C
Authority
CA
Canada
Prior art keywords
methyl
thiophene
bromo
isoxazolyl
sulfonamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002288439A
Other languages
English (en)
Other versions
CA2288439A1 (fr
Inventor
Ming Fai Chan
Bore Gowda Raju
Adam Kois
Erik Joel Verner
Chengde Wu
Rosario Sylvestre Castillo
Venkatachalapathi Yalamoori
Vitukudi Narayanaiyengar Balaji
Timothy Kogan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Encysive Pharmaceuticals Inc
Original Assignee
ImmunoPharmaceutics Inc
Texas Biotechnology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/477,223 external-priority patent/US5594021A/en
Application filed by ImmunoPharmaceutics Inc, Texas Biotechnology Corp filed Critical ImmunoPharmaceutics Inc
Priority claimed from CA002217169A external-priority patent/CA2217169C/fr
Publication of CA2288439A1 publication Critical patent/CA2288439A1/fr
Application granted granted Critical
Publication of CA2288439C publication Critical patent/CA2288439C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA002288439A 1995-04-04 1996-04-04 Biphenyl sulfonamides et leurs derives modulant l'activite de l'endotheline Expired - Fee Related CA2288439C (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US41619995A 1995-04-04 1995-04-04
US41707595A 1995-04-04 1995-04-04
US08/417,075 1995-04-04
US08/416,199 1995-04-04
US08/477,223 US5594021A (en) 1993-05-20 1995-06-06 Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin
US08/477,226 1995-06-06
CA002217169A CA2217169C (fr) 1995-04-04 1996-04-04 Thienyl-, furyl-, pyrrolyl- et biphenyl sulfonamides et leurs derives modulant l'activite de l'endotheline

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002217169A Division CA2217169C (fr) 1995-04-04 1996-04-04 Thienyl-, furyl-, pyrrolyl- et biphenyl sulfonamides et leurs derives modulant l'activite de l'endotheline

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA 2420614 Division CA2420614A1 (fr) 1995-04-04 1996-04-04 Biphenylsulfonamides et leurs derives qui modulent l'activite de l'endotheline

Publications (2)

Publication Number Publication Date
CA2288439A1 CA2288439A1 (fr) 1996-10-10
CA2288439C true CA2288439C (fr) 2003-04-01

Family

ID=27427394

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002288439A Expired - Fee Related CA2288439C (fr) 1995-04-04 1996-04-04 Biphenyl sulfonamides et leurs derives modulant l'activite de l'endotheline

Country Status (1)

Country Link
CA (1) CA2288439C (fr)

Also Published As

Publication number Publication date
CA2288439A1 (fr) 1996-10-10

Similar Documents

Publication Publication Date Title
US5962490A (en) Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
CA2217169C (fr) Thienyl-, furyl-, pyrrolyl- et biphenyl sulfonamides et leurs derives modulant l'activite de l'endotheline
US5594021A (en) Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin
RU2151144C1 (ru) Сульфонамиды, фармацевтическая композиция на их основе, способ лечения эндотелин-зависимых заболеваний, способ ингибирования связывания эндотелинового пептида с эндотелин a-(етa) или b-(етb) рецепторами, способ изменения вызываемой эндотелиновыми рецепторами активности.
AU749167B2 (en) Sulfonamides for treatment of endothelin-mediated disorders
US6248767B1 (en) Formulation of sulfonamides for treatment of endothelin-mediated disorders
US5571821A (en) Sulfonamides and derivatives thereof that modulate the activity of endothelin
US6613804B2 (en) Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US6342610B2 (en) N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
CA2288439C (fr) Biphenyl sulfonamides et leurs derives modulant l'activite de l'endotheline
AU726595B2 (en) Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
CA2420614A1 (fr) Biphenylsulfonamides et leurs derives qui modulent l'activite de l'endotheline

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130404